Ali Zarezadeh Mehrabadi
Overview
Explore the profile of Ali Zarezadeh Mehrabadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehrabadi A, Tat M, Alvanegh A, Roozbahani F, Esmaeili Gouvarchin Ghaleh H
Front Immunol
. 2024 Mar;
15:1343378.
PMID: 38464532
Bi- or tri-specific T cell engagers (BiTE or TriTE) are recombinant bispecific proteins designed to stimulate T-cell immunity directly, bypassing antigen presentation by antigen-presenting cells (APCs). However, these molecules suffer...
2.
Mehrabadi A, Shahba F, Khorramdelazad H, Aghamohammadi N, Karimi M, Bagherzadeh K, et al.
Crit Rev Oncol Hematol
. 2023 Nov;
193:104200.
PMID: 37981104
IL-1, plays a role in some pathological inflammatory conditions. This pro-inflammatory cytokine also has a crucial role in tumorigenesis and immune responses in the tumor microenvironment (TME). IL-1 receptor accessory...
3.
Aghamohamadi N, Shahba F, Mehrabadi A, Khorramdelazad H, Karimi M, Falak R, et al.
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1139692.
PMID: 37654571
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic and causes severe symptoms; in addition to respiratory syndromes, patients might experience other severe conditions such as digestive complications and...
4.
Khorramdelazad H, Kazemi M, Azimi M, Aghamajidi A, Mehrabadi A, Shahba F, et al.
Eur J Pharmacol
. 2022 May;
927:175051.
PMID: 35618037
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is currently the major global health problem. Still, it continues to infect people globally and...
5.
Mehrabadi A, Aghamohamadi N, Khoshmirsafa M, Aghamajidi A, Pilehforoshha M, Massoumi R, et al.
Immunology
. 2022 Mar;
166(1):38-46.
PMID: 35231129
Interleukin-1 receptor accessory protein (IL-1RAcP) is a member of the immunoglobulin superfamily proteins consisting of soluble and membranous isoforms. IL-1RAcP plays an essential role in the signaling of the IL-1...
6.
Mehrabadi A, Aghamohamadi N, Abolhassani H, Aghamohammadi A, Rezaei N, Yazdani R
J Clin Immunol
. 2022 Jan;
42(3):653-664.
PMID: 35084691
Background: Common variable immunodeficiency (CVID) is an inborn error of immunity (IEI) characterized by various clinical manifestations such as hypogammaglobulinemia, recurrent infections, and autoimmune diseases. Among different clinical manifestations, skin...
7.
Mehrabadi A, Roozbahani F, Ranjbar R, Farzanehpour M, Shahriary A, Dorostkar R, et al.
World J Surg Oncol
. 2022 Jan;
20(1):16.
PMID: 35027068
Background: Cancer is one of the critical issues of the global health system with a high mortality rate even with the available therapies, so using novel therapeutic approaches to reduce...
8.
Mehrabadi A, Ranjbar R, Farzanehpour M, Shahriary A, Dorostkar R, Hamidinejad M, et al.
Biomed Pharmacother
. 2021 Dec;
146:112512.
PMID: 34894519
Although tremendous advancements in cancer therapy over the last several years, cancer still is a complex illness to cure. Traditional cancer treatments, including chemotherapy, radiotherapy, and surgery, have a poor...